Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4n5n | NAP | Acetoacetyl-CoA reductase | 1.1.1.36 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4n5n | NAP | Acetoacetyl-CoA reductase | 1.1.1.36 | 1.000 | |
| 4nbw | NAD | Short-chain dehydrogenase/reductase SDR | / | 0.518 | |
| 3sj7 | NDP | 3-oxoacyl-(Acyl-carrier-protein) reductase, putative | / | 0.512 | |
| 4fw8 | NAI | 3-oxoacyl-(Acyl-carrier-protein) reductase | / | 0.502 | |
| 4qec | NAP | ElxO | / | 0.498 | |
| 4k6f | NAP | Putative Acetoacetyl-CoA reductase | / | 0.495 | |
| 2fr0 | NDP | 6-deoxyerythronolide-B synthase EryA1, modules 1 and 2 | / | 0.481 | |
| 4dc0 | NDP | Putative ketoacyl reductase | 1.3.1 | 0.481 | |
| 1g6k | NAD | Glucose 1-dehydrogenase | 1.1.1.47 | 0.478 | |
| 4dbz | NDP | Putative ketoacyl reductase | 1.3.1 | 0.478 | |
| 2hsd | NAD | 3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase | 1.1.1.53 | 0.469 | |
| 4ure | 1PS | Cyclohexanol dehydrogenase | / | 0.466 | |
| 1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.462 | |
| 3tsc | NAD | Uncharacterized protein | / | 0.459 | |
| 4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.454 | |
| 4qed | NAP | ElxO | / | 0.454 | |
| 4hp8 | NAP | 2-deoxy-D-gluconate 3-dehydrogenase | / | 0.452 | |
| 4q71 | FAD | Bifunctional protein PutA | / | 0.448 | |
| 1bvr | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.446 | |
| 5jla | NAD | Putative short-chain dehydrogenase/reductase | / | 0.443 |